Oramed Pharmaceuticals Ratios and Metrics

Market cap in millions ILS. Fiscal year is January - December.

Millions ILS. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Apr '25 Apr 2, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Market Capitalization	333	355	336	1,655	1,692	355	Upgrade
Market Cap Growth	5.88%	5.88%	-79.72%	-2.19%	376.42%	74.21%	Upgrade
Enterprise Value	-195	-167	-33	1,094	1,382	214	Upgrade
Last Close Price	7.99	8.51	8.20	38.83	40.80	13.77	Upgrade
PE Ratio	-	-	16.87	-	-	-	Upgrade
PS Ratio	-	69.54	174.08	200.54	40.73	Upgrade
PB Ratio	0.67	0.67	0.57	3.11	3.26	-	Upgrade
P/TBV Ratio	0.67	0.67	0.57	3.10	3.27	-	Upgrade
EV/Sales Ratio	-	-	115.15	163.83	24.59	Upgrade
EV/FCF Ratio	6.34	-	-	-	-	-	Upgrade
Debt / Equity Ratio	0.00	0.00	0.32	0.01	0.00	-	Upgrade
Asset Turnover	-	-	0.01	0.02	-	-	Upgrade
Quick Ratio	24.97	24.97	3.05	27.10	19.85	-	Upgrade
Current Ratio	25.19	25.19	3.06	27.34	20.08	-	Upgrade
Return on Equity (ROE)	-12.39%	-12.39%	3.24%	-23.77%	-	-	Upgrade
Return on Assets (ROA)	-4.25%	-4.25%	-5.16%	-14.95%	-	-	Upgrade
Return on Capital (ROIC)	-4.44%	-4.44%	-5.38%	-15.90%	-	-	Upgrade
Earnings Yield	-20.88%	-19.54%	5.93%	-7.77%	-6.44%	-19.89%	Upgrade
FCF Yield	-9.23%	-8.64%	-11.32%	-6.04%	-6.14%	-23.31%	Upgrade
Buyback Yield / Dilution	-0.65%	-0.65%	-4.02%	-5.08%	-52.14%	-39.76%	Upgrade

Updated Nov 7, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.